Customer Now Have Ability to Earn Commissions Based on New Customer Referrals
SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.
A current customer who is signed up under the new affiliate program, now has the opportunity to receive a 15% commission on any sales made to the customers they have referred to the company.
“We are excited to have this new program up and running, showing our appreciation to our dedicated customer base,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “One of the most effective ways for people to learn about HempMeds® products in through online social media and word of mouth, with this new affiliate program we have given even more of an incentive to our current customer base to share the benefits of our products.”
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink: MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC: MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. LEGAL DISCLOSURE Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.